NYSE:OSTX | Cash Flow Statement | OS Therapies Inc

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$8.63M
2026-03-31-$10.4M-$4.56M$5.21M
2025-12-31-$13.46M-$3.73M$0.00$2.12M
2025-09-30-$6.88M
2025-06-30-$4.54M
2025-03-31-$3.88M-$3.44M-$173,636.00$1.05M
2024-12-31-$2.99M-$2.37M$6.05M
2024-09-30-$2.88M
2024-06-30-$1.56M
2024-03-31-$1.46M-$641,729.00$702,978.00
2023-12-31-$1.46M-$871,160.00$19.00$894,064.00
2023-09-30-$1.97M
2023-06-30-$2.51M
2023-03-31-$1.85M-$428,186.00$1,145.00$610,775.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$28.75M-$14.24M-$466,423.00$9.44M
2024-12-31-$8.88M-$7.28M$12.78M
2023-12-31-$7.79M-$3.01M$1,145.00$2.87M